Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Sideromycin antibiotics are conjugant of siderophore and antibiotic. Sideromycin-like antibiotic HDM was isolated form the combined-culture of Streptomyces sp. HOK021 and Tsukamurella pulmonis TP-B0596. HDM was a chimeric compound of two units; bacterial FabF inhibitor platensimycin and bacterial siderophore enterobactin, connected through thioester bond. In this study, biosynthetic gene clusters for platensimycin and enterobactin was identified from the complete genome sequence of Streptomyces sp. HOK021. Additionally, physicochemical property of sideromycins including HDMs, salmycins, and ferrimycins in LC-MS/MS were elucidated. Obtained knowledge will be applied for further screening to discover novel sideromycin antibiotics.
|